Evidence map›Paper›PMID 38339217›Full record

ReviewInternational journal of molecular sciences2024

Hyperpolarized Xenon-129 Chemical Exchange Saturation Transfer (HyperCEST) Molecular Imaging: Achievements and Future Challenges.

Viktoriia Batarchuk, Yurii Shepelytskyi, Vira Grynko, Antal Halen Kovacs, Aaron Hodgson, Karla Rodriguez, Ruba Aldossary, Tanu Talwar, Carson Hasselbrink, Iulian C Ruset and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Multi-Vendor and Multi-Site Characterization ofMagnetic resonance in medicine · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Viktoriia BatarchukChemistry Department, Lakehead University, Thunder Bay, ON P7B 5E1, Canada.
Yurii ShepelytskyiChemistry Department, Lakehead University, Thunder Bay, ON P7B 5E1, Canada.ORCID 0000-0001-5526-7958
Vira GrynkoThunder Bay Regional Health Research Institute, Thunder Bay, ON P7B 6V4, Canada.ORCID 0000-0002-9580-0072
Antal Halen KovacsApplied Life Science Program, Lakehead University, Thunder Bay, ON P7B 5E1, Canada.
Aaron HodgsonPhysics Program, Lakehead University, Thunder Bay, ON P7B 5E1, Canada.
Karla RodriguezChemistry Department, Lakehead University, Thunder Bay, ON P7B 5E1, Canada.
Ruba AldossaryThunder Bay Regional Health Research Institute, Thunder Bay, ON P7B 6V4, Canada.ORCID 0009-0007-4741-8913
Tanu TalwarChemistry Department, Lakehead University, Thunder Bay, ON P7B 5E1, Canada.
Carson HasselbrinkChemistry & Biochemistry Department, California Polytechnic State University, San Luis Obispo, CA 93407-005, USA.
Iulian C RusetXemed LCC, Durham, NH 03824, USA.
Brenton DeBoefDepartment of Chemistry, University of Rhode Island, Kingston, RI 02881, USA.
Mitchell S AlbertChemistry Department, Lakehead University, Thunder Bay, ON P7B 5E1, Canada.
Thunder Bay Regional Research Institute · CALakehead University · CACalifornia Polytechnic State University · USUniversity of Rhode Island · USXemed (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular magnetic resonance imaging (MRI) is an emerging field that is set to revolutionize our perspective of disease diagnosis, treatment efficacy monitoring, and precision medicine in full concordance with personalized medicine. A wide range of hyperpolarized (HP)

Indexed as

Magnetic Resonance ImagingXenon IsotopesMagnetic Resonance SpectroscopySolubilityXenonXenonXenon-129Xenon Isotopesbiosensorschemical exchange saturation transferHyperCESThyperpolarized MRImolecular imagingNMRpersonalized medicinexenon

Identifiers

PMID38339217
PMCPMC10856220
OpenAlexW4391531082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.